In our study, we discovered that patients with high WDHD1 expression in BRCA, KIRP, and LIHC and low WDHD1 expression in ACC were more sensitive to rapamycin treatment (Fig. 7A). This evidence concerns the gene WDHD1 and adrenal cortex carcinoma.